Literature DB >> 16954390

Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis.

Mark I Fowler1, Kiave Y Ho Wang Yin, Holly E Humphries, John E Heckels, Myron Christodoulides.   

Abstract

The rationale for the present study was to determine how different species of bacteria interact with cells of the human meninges in order to gain information that would have broad relevance to understanding aspects of the innate immune response in the brain. Neisseria lactamica is an occasional cause of meningitis in humans, and in this study we investigated the in vitro interactions between N. lactamica and cells derived from the leptomeninges in comparison with the closely related organism Neisseria meningitidis, a major cause of meningitis worldwide. N. lactamica adhered specifically to meningioma cells, but the levels of adherence were generally lower than those with N. meningitidis. Meningioma cells challenged with N. lactamica and N. meningitidis secreted significant amounts of the proinflammatory cytokine interleukin-6 (IL-6), the C-X-C chemokine IL-8, and the C-C chemokines monocyte chemoattractant protein 1 (MCP-1) and RANTES, but it secreted very low levels of the cytokine growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF). Thus, meningeal cells are involved in the innate host response to Neisseria species that are capable of entering the cerebrospinal fluid. The levels of IL-8 and MCP-1 secretion induced by both bacteria were essentially similar. By contrast, N. lactamica induced significantly lower levels of IL-6 than N. meningitidis. Challenge with the highest concentration of N. lactamica (10(8) CFU) induced a small but significant down-regulation of RANTES secretion, which was not observed with lower concentrations of bacteria. N. meningitidis (10(6) to 10(8) CFU) also down-regulated RANTES secretion, but this effect was significantly greater than that observed with N. lactamica. Although both bacteria were unable to invade meningeal cells directly, host cells remained viable on prolonged challenge with N. lactamica, whereas N. meningitidis induced death; the mechanism was overwhelming necrosis with no significant apoptosis. It is likely that differential expression of modulins between N. lactamica and N. meningitidis contributes to these observed differences in pathogenic potential.

Entities:  

Mesh:

Year:  2006        PMID: 16954390      PMCID: PMC1695519          DOI: 10.1128/IAI.00644-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  A comparative analysis of pilin genes from pathogenic and nonpathogenic Neisseria species.

Authors:  E L Aho; A M Keating; S M McGillivray
Journal:  Microb Pathog       Date:  2000-02       Impact factor: 3.738

Review 2.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Identification of regions of the chromosome of Neisseria meningitidis and Neisseria gonorrhoeae which are specific to the pathogenic Neisseria species.

Authors:  A Perrin; X Nassif; C Tinsley
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Invasion by Neisseria meningitidis varies widely between clones and among nasopharyngeal mucosae derived from adult human hosts.

Authors:  Robert Townsend; Linda Goodwin; Tania M Stevanin; Paul B Silcocks; Andrew Parker; Martin C J Maiden; Robert C Read
Journal:  Microbiology       Date:  2002-05       Impact factor: 2.777

5.  Differential gene expression during meningeal-meningococcal interaction: evidence for self-defense and early release of cytokines and chemokines.

Authors:  D B Wells; P J Tighe; K G Wooldridge; K Robinson; D A Ala' Aldeen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis.

Authors:  B Linz; M Schenker; P Zhu; M Achtman
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

7.  Interactions of Neisseria meningitidis with cells of the human meninges.

Authors:  S J Hardy; M Christodoulides; R O Weller; J E Heckels
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis.

Authors:  P Massari; Y Ho; L M Wetzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

9.  Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).

Authors:  H Uronen; A J Williams; G Dixon; S R Andersen; P Van Der Ley; M Van Deuren; R E Callard; N Klein
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

10.  Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines.

Authors:  Myron Christodoulides; Benjamin L Makepeace; Kris A Partridge; Davindaur Kaur; Mark I Fowler; Roy O Weller; John E Heckels
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  13 in total

1.  HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway.

Authors:  Ankit Shah; Dhirendra P Singh; Shilpa Buch; Anil Kumar
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

2.  The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences Toll-like receptor 2-dependent cell activation.

Authors:  Deana N Toussi; Margaretha Carraway; Lee M Wetzler; Lisa A Lewis; Xiuping Liu; Paola Massari
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

3.  Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling.

Authors:  Xiuping Liu; Lee M Wetzler; Laura Oliveira Nascimento; Paola Massari
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

Review 4.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

5.  Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals.

Authors:  Constance M John; Mingfeng Liu; Nancy J Phillips; Zhijie Yang; Courtney R Funk; Lindsey I Zimmerman; J McLeod Griffiss; Daniel C Stein; Gary A Jarvis
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

6.  Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica.

Authors:  Hazel En En Wong; Ming-Shi Li; J Simon Kroll; Martin L Hibberd; Paul R Langford
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

7.  The biology of Neisseria adhesins.

Authors:  Miao-Chiu Hung; Myron Christodoulides
Journal:  Biology (Basel)       Date:  2013-07-29

8.  Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro.

Authors:  Khalil Alkuwaity; Alexander Taylor; John E Heckels; Kelly S Doran; Myron Christodoulides
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

9.  HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.

Authors:  Anantha R Nookala; Ankit Shah; Richard J Noel; Anil Kumar
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Leptomeningeal cells transduce peripheral macrophages inflammatory signal to microglia in reponse to Porphyromonas gingivalis LPS.

Authors:  Yicong Liu; Zhou Wu; Xinwen Zhang; Junjun Ni; Weixian Yu; Yanmin Zhou; Hiroshi Nakanishi
Journal:  Mediators Inflamm       Date:  2013-12-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.